| ID | 1098 |
| Name of the vaccine | Tetanus Toxoid Adsorbed |
| Microbe | Bacteria |
| Disease name | Tetanus (Lock Jaw) |
| Name of bacteria | Clostridium tetani |
| Type of vaccine | Toxoid |
| Nucleic acid content | DNA |
| Age | 7 years and older |
| Description of the vaccine | Prevents the symptoms of tetanus. |
| Name of the manufacturer | Sanofi Pasteur Ltd |
| Name of the manufacturing country | United States, Canada |
| Year of manufacture | NA |
| Clinical Phase status | Approved |
| Bacterial strain | An obligate anaerobic bacillus, which is gram positive. |
| Efficacy | NA |
| Vaccine formulation | Sterile suspension |
| Dosage | Primary immunisation - Three doses.
Booster- Single dose at 10 year interval. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | Active immunization against tetanus. |
| Export | NA |
| Approval | NA |
| Adjuvant | Aluminium potassium sulphate |
| Repurposing | NA |
| Side effects of vaccine | Redness, pain, fainting, mild headache, mild vomiting, mild fussiness, irritability, crying, confusion, joint pain and body ache. |
| Post vaccination | NA |
| Dose type | Combination (4 doses) |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NA |
| Reference | http://www.violinet.org/vaxquery/vaccine_detail.php?c_vaccine_id=631&keywords= |
| Other name | NA |
| Additional Links | https://www.rxlist.com/tetanus-toxoid-adsorbed-drug.htm#medguide
|